Table: Taiko Pharmaceutical -2025 parent results

Taiko Pharmaceutical Co

13/02/2026 06:41

Feb 13 (Reuters)- 
          Taiko Pharmaceutical Co Ltd 
          PARENT-ONLY FINANCIAL HIGHLIGHTS 
     (in billions of yen unless specified)
                 Year ended      Year ended       Year to     NEXT     
              Dec 31, 2025    Dec 31, 2024   Dec 31, 2026     YEAR     
                 LATEST         YEAR-AGO        COMPANY      COMPANY   
                 RESULTS         RESULTS       FORECAST    H1 FORECAST 
  Sales           5.61            5.55                                 
               (+1.1 pct)      (+2.1 pct)                              
  Operating      282 mln         501 mln                               
               (-43.7 pct)                                             
  Recurring      332 mln         947 mln                               
               (-64.9 pct)                                             
  Net            781 mln          1.17                                 
               (-33.3 pct)                                             
  EPS           15.56 yen       23.34 yen                              
  Ann Div       3.30 yen           NIL         3.50 yen                
  -Q2 Div          NIL             NIL            NIL                  
  -Q4 Div       3.30 yen           NIL         3.50 yen                
  
  NOTE - Taiko Pharmaceutical Co Ltd. 
  To see Company Overview page, click reuters://REALTIME/verb=CompanyData/ric=4574.T